While Elon Musk's Neuralink is still stuck in the clinical testing phase, China has created facts:
The national regulatory authority (NMPA) has approved the world's first invasive brain-computer interface (BCI) system for commercial sale.
The product from Shanghai startup Neuracle Technology marks the starting signal for a new global billion-dollar market.
The "thought glove" for paralyzed patients
The approved system is specifically designed for patients with spinal cord injuries who can no longer move their hands.
Technology: A coin-sized, wireless implant is placed on the brain surface (without penetrating the tissue). It reads neural signals and translates them into commands.
Hardware: The signals control a robotic glove that works with air pressure and enables patients to grasp objects solely through the power of their thoughts.
Limitation: The current approval only applies to patients who still have residual function in their upper arm.
Alibaba & Tencent jump in
Parallel to the approval, there was another financial earthquake on Friday: BCI startup StairMed raised over 500 million yuan (approx. $72.6 million) in a funding round led by Alibaba.
First double pact: StairMed is the first company in the industry to be financed by both Alibaba and Tencent.
Scaling: The goal is 40 implantations by the end of 2026 – which would allow StairMed to overtake Neuralink's case numbers (currently 21).
Stock rally: Following the news, shares of BCI-related companies in Hong Kong and Shenzhen (e.g., Sanbo Hospital, Inkon Life) rose by over 10%.
Beijing has defined BCI as one of six strategic future industries.
Target: "Two to three" global players by 2030. The government has pledged to accelerate approvals and create reimbursement guidelines – before products even hit the market.
All details & data: Scientific American, SCMP, Bloomberg
Get These Insights Every Morning
Join 18,000+ professionals who start their day with Asiabits. Free, every weekday, straight from Shanghai.
Subscribe Free →
